Received May 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y012508 | — |
No additional AE reported.; patient was administered GARDASIL9 during a temperature excursion.; This spontaneous report was received from a health care business professional and refers to a patient of unknown age and gender. The patient's medical, concurrent conditions were not reported, and concomitant therapies were not reported. On 28-APR-2025, the patient was vaccinated with an improper storage dose of dose of Human Papillomavirus 9-valent Vaccine, Recombinant Injection (GARDASIL9), prefilled syringe (lot #Y012508, expiration date: 01-JAN-2027) (dose and frequency reported as 1 dose), for prophylaxis. The administered doses of the vaccine experienced a temperature excursion 0 degree centigrade for 1 hour. No previous temperature excursion was reported. There was no adverse effect reported. No product quality complaint was involved.